These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15917553)

  • 1. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.
    Wehbeh W; Rojas-Diaz R; Li X; Mariano N; Grenner L; Segal-Maurer S; Tommasulo B; Drlica K; Urban C; Rahal JJ
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2495-7. PubMed ID: 15917553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone-Resistant
    Arias B; Kovacec V; Vigliarolo L; Suárez M; Tersigni C; Müller L; Lopardo H; Bonofiglio L; Mollerach M
    Microb Drug Resist; 2019 Jun; 25(5):739-743. PubMed ID: 30676886
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil.
    Barros RR; Kegele FC; Paula GR; Brito MA; Duarte RS
    Braz J Infect Dis; 2012; 16(5):476-8. PubMed ID: 22980583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Streptococcus agalactiae highly resistant to fluoroquinolones].
    Miró E; Rebollo M; Rivera A; Alvarez MT; Navarro F; Mirelis B; Coll P
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):562-3. PubMed ID: 17125675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.
    Kawamura Y; Fujiwara H; Mishima N; Tanaka Y; Tanimoto A; Ikawa S; Itoh Y; Ezaki T
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3605-9. PubMed ID: 14576126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance.
    Simoni S; Vincenzi C; Brenciani A; Morroni G; Bagnarelli P; Giovanetti E; Varaldo PE; Mingoia M
    Microb Drug Resist; 2018 Apr; 24(3):225-231. PubMed ID: 28783417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.
    Wu HM; Janapatla RP; Ho YR; Hung KH; Wu CW; Yan JJ; Wu JJ
    Antimicrob Agents Chemother; 2008 May; 52(5):1888-90. PubMed ID: 18299411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea.
    Ki M; Srinivasan U; Oh KY; Kim MY; Shin JH; Hong HL; Dang T; Britt Z; Foxman B
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3199-205. PubMed ID: 22752224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
    Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.
    Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3570-2. PubMed ID: 15328129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.
    Piccinelli G; Gargiulo F; Corbellini S; Ravizzola G; Bonfanti C; Caruso A; De Francesco MA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2466-9. PubMed ID: 25666148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR; Lütticken R; Al-Lahham A
    Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
    Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
    Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
    Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS; Diekema DJ; Heilmann KP; Almer LS; Shortridge VD; Zeitler R; Flamm RK; Doern GV
    Clin Infect Dis; 2003 Feb; 36(3):380-3. PubMed ID: 12539083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005.
    Nichol KA; Adam HJ; Karlowsky JA; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1190-4. PubMed ID: 18180349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
    Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
    J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus.
    Oizumi N; Kawabata S; Hirao M; Watanabe K; Okuno S; Fujiwara T; Kikuchi M
    J Infect Chemother; 2001 Sep; 7(3):191-4. PubMed ID: 11810583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.
    Kimura K; Nagano N; Nagano Y; Suzuki S; Wachino J; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2013 Mar; 68(3):539-42. PubMed ID: 23111853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.
    Dutta S; Kawamura Y; Ezaki T; Nair GB; Iida K; Yoshida S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1660-1. PubMed ID: 15793166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.